Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma
Clinical trial NCT00948922 · COMPLETED
Trial details
- NCT number
- NCT00948922
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-18
- Primary completion
- 2017-04-20
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.